From RairFoundation.com…
“WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients.” World Health Organization
Remdesivir is a highly toxic drug that medical officials advocate in the fight against Covid. But what is it, and why do the same officials ferociously defend it when there are known side effects that are deadly?
The FDA approved it under the name Veklury for IVs in non-hospitalized outpatient treatment on January 27, 2022. They also terminated approval of two monoclonal antibody drugs, saying they “didn’t work” for the Omicron variant. Those two drugs had known life-extending properties for Covid patients. Let’s have a look at the controversy and why there may be more to this than meets the eye.
